Plans to overhaul the EU’s medicines legislation took a major step forward on 19 March when a European Parliament committee voted to approve the “pharmaceutical package” published by the European Commission in April 2023, albeit with some major changes to the proposals on regulatory data protection (RDP).
As part of a set of compromise amendments intended to reconcile opposing political positions on the proposals, the parliament’s environment...





